Bhattacharjee P, Dvoracsko S, Pointeau O, Kundu B, et al. Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders. Metabolism 2025;170:156291.
PMID: 40368157